ASRM Center for Policy and Leadership Releases Policy Report on Gestational Carrier Pregnancies
January 27, 2026
For Immediate Release
Washington, DC — The ASRM Center for Policy and Leadership (CPL) released a new report examining gestational carrier policy in the United States, offering an evidence-based framework and key policy considerations for lawmakers. Gestational carrier (GC) arrangements provide a family-building option for patients with documented medical indications using embryos created through in vitro fertilization (IVF) transferred to the uterus of a GC who is not the genetic parent of the child.
The report, Gestational Carrier Policy in the United States: Regulatory Overview and Key Considerations for Policy Development, outlines key policy considerations for lawmakers evaluating gestational carrier legislation, informed by clinical guidance from the American Society for Reproductive Medicine (ASRM) and the Society for Assisted Reproductive Technology, including:
The report also urges lawmakers to consider whether proposed policies ask the right threshold questions, including whether legislation is narrowly tailored, grounded in data rather than anecdote, consistent with clinical best practices, and protective of access to medically indicated care without creating unnecessary barriers.
“As policymakers and courts grapple with questions surrounding gestational carriers and assisted reproduction, it is critical that they ground policy decisions in clinical data and established medical standards,” said Rebecca O’Connor, JD, Director of the ASRM CPL. “This report is intended to help decision-makers separate anecdotes from evidence, protect patients and gestational carriers, and avoid unintended consequences that could undermine access to medically indicated care.”
Gestational carrier pregnancies remain rare in the United States, occurring at a rate of approximately 13.7 per 100,000 deliveries nationwide. While use has increased gradually over time, gestational carriers account for just 1.5 percent of assisted reproductive technology cycles, underscoring that these arrangements represent a highly specialized form of medically indicated care rather than a widespread practice. For some hopeful parents, including many same-sex couples and patients who cannot carry a pregnancy, gestational carriers are the only pathway to having a biologically related child.
The full report is available here
For Immediate Release
Washington, DC — The ASRM Center for Policy and Leadership (CPL) released a new report examining gestational carrier policy in the United States, offering an evidence-based framework and key policy considerations for lawmakers. Gestational carrier (GC) arrangements provide a family-building option for patients with documented medical indications using embryos created through in vitro fertilization (IVF) transferred to the uterus of a GC who is not the genetic parent of the child.
The report, Gestational Carrier Policy in the United States: Regulatory Overview and Key Considerations for Policy Development, outlines key policy considerations for lawmakers evaluating gestational carrier legislation, informed by clinical guidance from the American Society for Reproductive Medicine (ASRM) and the Society for Assisted Reproductive Technology, including:
- Weighing the real-world consequences of new laws, including how they impact patients, healthcare providers, and taxpayers, to ensure that any resulting costs are clearly justified by a demonstrable public benefit.
- Ensuring transparency, informed consent, and access to independent legal counsel so gestational carriers and intended parents clearly understand their rights and responsibilities.
- Aligning laws with established medical standards, including evidence-based screening, testing, and psychological evaluation, to protect the health of gestational carriers and support safe, healthy family building.
The report also urges lawmakers to consider whether proposed policies ask the right threshold questions, including whether legislation is narrowly tailored, grounded in data rather than anecdote, consistent with clinical best practices, and protective of access to medically indicated care without creating unnecessary barriers.
“As policymakers and courts grapple with questions surrounding gestational carriers and assisted reproduction, it is critical that they ground policy decisions in clinical data and established medical standards,” said Rebecca O’Connor, JD, Director of the ASRM CPL. “This report is intended to help decision-makers separate anecdotes from evidence, protect patients and gestational carriers, and avoid unintended consequences that could undermine access to medically indicated care.”
Gestational carrier pregnancies remain rare in the United States, occurring at a rate of approximately 13.7 per 100,000 deliveries nationwide. While use has increased gradually over time, gestational carriers account for just 1.5 percent of assisted reproductive technology cycles, underscoring that these arrangements represent a highly specialized form of medically indicated care rather than a widespread practice. For some hopeful parents, including many same-sex couples and patients who cannot carry a pregnancy, gestational carriers are the only pathway to having a biologically related child.
The full report is available here
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Press Releases
Check out these press releases as well
ASRM Research Institute Announces Recipients of 2026 Research Award Programs
ASRM Research Institute names 24 recipients of its 2026 research awards, funding innovative studies to advance fertility medicine and reproductive health.
ASRM Physician Members Warn State Reporting Bills Could Turn Fertility Care Into a Political Target
ASRM warns state IVF reporting bills could threaten patient privacy, fertility care, and access by replacing medical expertise with political oversight.
ASRM Center for Policy and Leadership Sponsors Petrie-Flom Center’s Annual Conference on Embryo Law and Ethics at Harvard Law School
ASRM and Harvard Law School convene experts to explore IVF policy, embryo law, personhood, AI-selected embryos, and reproductive ethics after Dobbs.
ASRM Calls for Applications for 2026 INNOVATE Pitch Tank Showcase
Apply for the 2026 ASRM INNOVATE Pitch Tank Showcase to pitch reproductive health innovations, compete for $10,000, and connect with investors.The News from ASRM
Latest News
An indispensable news digest for reproductive scientists, clinicians and allied health professionals. The Latest News posts are available to ASRM members in good standing only.
ASRM Press Releases/Bulletins
ASRM Press Releases and Bulletins are published by ASRM's Office of Public Affairs to inform the press and Society members of important recent developments.
Topic Resources
View more on the topic of assisted reproductive technologies
Group Spotlight: Society for Assisted Reproductive Technology
Learn how SART advances IVF care through national data, clinic standards, patient tools, and quality reporting to improve fertility treatment outcomes. Learn more about our friends at SART
ASRM Physician Members Warn State Reporting Bills Could Turn Fertility Care Into a Political Target
ASRM warns state IVF reporting bills could threaten patient privacy, fertility care, and access by replacing medical expertise with political oversight. View the Press Release
Fertility and Sterility On Air - TOC: July 2026
Fertility and Sterility On Air covers latest reproductive medicine research, journal highlights, AI sperm detection, ART studies, and expert discussion roundup. Listen to the Episode
Policy Update from the ASRM Office of Public Affairs: SART Membership Now Mandatory in Tennessee
ASRM-backed Tennessee law makes SART membership mandatory for ART clinic certification, strengthening fertility care standards and oversight. View the Policy Update on Tennessee law
Fertility and Sterility On Air - Roundtable: In Vitro Gametogenesis
This week, we welcome Dr. Paula Amato and Professor Glenn Cohen to discuss the legal and ethical implications of in vitro gametogenesis (IVG). Listen to the Episode
ASRM Center for Policy and Leadership Releases Policy Report on Gestational Carrier Pregnancies
ASRM Center for Policy and Leadership released a report discussing gestational carrier policy in the U.S. discussing it's impact and how lawmakers should proceed going forward. View the Press Release
ASRM PRIMED scholar Dr. Caiyun Liao Publishes Article on RRM in JAMA
A new Viewpoint warns about the growing politicization and promotion of “restorative reproductive medicine." View the Press Release
ASRM Ethics and Practice Committees Release New Report Concluding Polygenic Embryo Screening Is Not Ready for Clinical Use
New analysis finds that PGT-P lacks proven clinical utility and raises significant scientific and ethical concerns. View the Press Release
Unlocking the Future of IVF: Navigating the Complex World of IVF Genomics
Explore the rise of IVF genomics, from PGT-A to WGS and polygenic risk scores, with insights on ethics, costs, and future implications for embryo screening. Read the Blog post
Assisted reproduction with advancing paternal and maternal age: an Ethics Committee opinion (2025)
Explore ethical considerations in assisted reproduction for older parents, balancing reproductive autonomy with potential offspring well-being. View the Committee Opinion
Code O09.01 vs O09.811 for Pregnancy Patients
Is code O09.01 acceptable for all pregnancy patients, or for same-sex cases View the Answer
Disclosure of medical errors and untoward events involving gametes and embryos: an Ethics Committee opinion (2024)
Medical providers have an ethical duty to disclose clinically significant errors involving gametes and embryos. View the Committee Opinion
Use of preimplantation genetic testing for monogenic adult-onset conditions: an Ethics Committee opinion (2024)
Preimplantation genetic testing for adult-onset monogenic diseases is ethically allowed when fully penetrant or conferring disease predisposition. View the Committee Opinion
When to use code Z31.83
When a patient is completing an approved fertility cycle, is it necessary View the Answer
Timed Intercourse Cycle Codes
Is it appropriate to utilize codes N97.8 or View the Answer
Billing Physician vs Service Physician
What physician’s name must be on the treatment notes and who we are permitted to bill to insurance for: View the Answer
Journal Club Global: Falha de implantação: realidade ou ilusão estatística?
Fertility and Sterility Global Journal Club from Brazil View the Video
The use of hormonal contraceptives in fertility treatments: a committee opinion (2024)
Hormonal contraception aids in the timing of ART cycles, reduce ovarian cysts at IVF cycle initiation, and optimize visualization before hysteroscopy. View the Committee Opinion
Opposition Rebuttal
ASRM's "Opposition Rebuttal" fact sheet counters common arguments against assisted reproductive technologies, offering evidence-based support for ART practices. View the advocacy points
Family members as gamete donors or gestational carriers: an Ethics Committee opinion (2024)
The use of adult intrafamilial gamete donors and gestational surrogates is ethically acceptable when all participants are fully informed and counseled. View the Committee Document
Semen analysis and thaw code
Can we use the semen analysis presence and motility (89300) code along with a reproductive tissue thaw code (89354) View the Answer
Coding for an endometrial biopsy/Mock cycle
We had patients request us to bill their insurance for the two monitoring visits and the Endo BX and change the diagnosis code to something that is payable. View the Answer
Billing for assisted hatching at biopsy and transfer
We would also like to know if you can bill assisted hatching with biopsy and then assisted hatching again during the transfer cycle. View the Answer
Diagnosis code for donation
What is the diagnosis code for an embryo donation versus egg donation? View the Answer
Financial ‘‘risk-sharing’’ or refund programs in assisted reproduction: an Ethics Committee opinion (2023)
Financial ‘‘risk-sharing’’ fee structures in programs charge patients a higher initial fee but provide reduced fees for subsequent cycles. View the Committee Document
Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline (2023)
Ovarian hyperstimulation syndrome is a serious complication associated with assisted reproductive technology. View the guideline
Guidance for coding limited or follow-up ultrasounds used during an IVF Cycle
I am a coder for a Reproductive Endocrinologist's office and am looking for some guidelines on limited or follow-up ultrasounds used during an IVF Cycle. View the Answer
Measurements to report with ultrasound codes
Are there clear guidelines as to what measurements are required in order to bill for each type of ultrasound? VIew the Answer
Billing for cryopreservation procedures on different days
I understand that if cryopreservation of oocytes is performed on two separate dates of service, each date of service was billable. View the Answer
Billing IVF lab work
We typically bill our IVF Lab work under the rendering provider who performs the VOR. Who should be the supervising provider for embryology billing? View the Answer
Estradiol Free versus Total
Should patients with fertility issues be billing Estradiol Free (82681) instead of Estradiol Total (82670)? View the Answer
IVF coverage denied for Z31.83 diagnosis code
My wife and I have been seeking IVF treatment and coverage was added for infertility treatment (up to $25,000) but our insurer keeps denying it. View the Answer
Cycle coordination fees and 99499, S4042
I reviewed cycle coordination fees, but see that there is no specific code for cycle management. View the Answer
Supervising provider for embryology billing
We typically bill our IVF Lab work under the rendering provider who performs the VOR. Who should be the supervising provider for embryology billing? View the Answer
Journal Club Global - Revisiting the STAR trial: The Fellows debate PGT-A
We are excited to host a debate covering the pros and cons of PGT-A and how new technologies should be validated before clinical implementation. View the Video
Informed consent in assisted reproduction: an Ethics Committee opinion (2023)
Informed consent is a process in which the patient is supported in developing an understanding of medical options. View the Ethics Committee Opinion
Unlisted Fertility Treatment CPT Code
Can you please refer me to an unlisted management CPT code for fertility treatment? View the Answer
Z Codes Vs. Procedure Codes For Fertility Preservation Counseling
I am trying to understand better when to use the procreative management code vs the fertility preservation counseling and procedure codes. View the Answer
Pregnancy Of Unknown Location
What is the most appropriate ICD-10 code for pregnancy of unknown location (not an ectopic pregnancy)? View the Answer
Pregnancy Ultrasound
Our practice does routine ultrasounds (sac check- 76817) at the end of an IVF cycle and bill with a diagnosis code O09.081, pregnancy resulting from ART. View the Answer
IUI Same Gender
When managing an IUI or IVF cycle for a female same sex couple or a patient that has no exposure to sperm, what ICD 10 diagnosis should be used? View the Answer
IVF Case Rates
What ICD-10 codes apply to case rates? View the Answer
Limited Monitoring Ultrasound
What is the appropriate code to use for a limited follow-up follicular transvaginal ultrasound? View the Answer
Limited Transvaginal Ultrasound
One of our clients received information that a repeat limited transvaginal ultrasound should be billed with a limited pelvic ultrasound code (76857). View the Answer
Monitoring E&M
Our group would like to know if others are billing an evaluation and management code for ultrasound and blood draw visits? View the Answer
Monitoring FET
What is the correct diagnosis code to use on the follicle ultrasound (76857) for a patient who is undergoing frozen embryo transfer (FET)? View the Answer
Monitoring Ovulation Induction By Nurses
We are considering the use of CPT code 99211 for encounters during cycle management as part of ovulation induction. View the Answer
Non-REI Board Certified MD Performing REI Procedures
My boss has a few follow up questions about a non-REI board certified MD performing REI procedures. View the Answer
In Vitro Maturation
Have CPT codes been established for maturation in vitro? View the Answer
Embryo Storage Fees For Multiple Cycles
We bill embryo storage 89342 for a year's storage. View the Answer
Endometrial Receptivity Analysis
Our physicians are going to start doing an Endometrial Receptivity Analysis. Do you know the appropriate CPT code that should be used?View the Answer
Flat Fee For Outside Monitoring
Can our office charge outside monitoring patients a flat fee to be seen? View the Answer
Donor Embryos
Could you give guidance for the correct ICD-10 code(s) to use when a patient is doing an Anonymous Donor Embryo Transfer cycle? View the Answer
Billing at an Outside Clinic for Lab Services
One of my physicians uses an outside facility to perform the retrievals and transfers. View the Answer
Board Certified Vs. Non-Board Certified Billing
Is coding/billing any different when a non-board certified or non-REI provider submits for REI procedure? View the Answer
Coding For Placement Of A Cervical Stitch
Physicians at our practice are placing a stitch and dilating the cervix after egg retrievals for those patients that have cervical stenosis. View the Answer
Assisted Hatching Billed With Embryo Biopsy
Do you know if both assisted hatching (89253) and embryo biopsy for PGS/PGD/CCS (89290/89291) can be billed during the same cycle? View the Answer
Mental-health Services During Assisted Reproduction
A summary of codes for Mental-health Services During Assisted Reproduction compiled by the ASRM Coding Committee. View the Coding Summary
Laboratory Procedures during ART Cycles
A listing of codes, compiled for a fresh ART cycle, transfer, biopsy, cryopreservation of embryos and oocytes, storage, and thawing. View the Coding Summary
Journal Club Global: Evidence for Immunologic Therapies in Women Undergoing ART
Reproductive immunology is perhaps one of the most controversial and promising fields within ART. View the Video
Comprehensive guidance for human embryology, andrology, and endocrinology laboratories: management and operations: a committee opinion (2022)
ASRM has published guidance and minimum standards for embryology and andrology laboratories. View the Committee Opinion
Journal Club Global - Best Practices of High Performing ART Clinics
This Fertility and Sterility Journal Club Global discusses February’s seminal article, “Common practices among consistently high-performing in vitro fertilization programs in the United States: a 10 year update.” View the Video
Journal Club Global - Fertilization rate as a novel indicator in ART results
This Journal Club Global discusses a provocative article recently published in Fertility and Sterility, discussing the results of a multicenter retrospective cohort study with the objective to appraise the fertilization rate as a predictive factor for cumulative live birth rate (CLBR). View the Video
Journal Club Global - Are We Approaching Automation in ART?
Some ART diagnostic devices are already available and offer objective tools of evaluation. View the Video
Guidance on the limits to the number of embryos to transfer: a committee opinion (2021)
ASRM's guidelines for the limits on the number of embryos to be transferred during IVF cycles have been further refined ... View the Committee Opinion
Role of tubal surgery in the era of assisted reproductive technology: a committee opinion (2021)
This document reviews surgical options for reparative tubal surgery and the factors that must be considered when deciding between surgical repair and IVF.View the Committee Opinion
Minimum standards for practices offering assisted reproductive technologies: a committee opinion (2021)
A framework for assisted reproductive technology (ART) programs that meet or exceed the requirements suggested by the Centers for Disease Control View the Committee Opinion
Journal Club Global - Recurrent Implantation Failures in ART: Myth or Reality?
Classically, implantation failures in ART were believed to result from alterations in embryo or endometrium quality.
View the Video
The role of immunotherapy in in vitro fertilization: a guideline (2018)
ASRM guideline evaluates current evidence on immunotherapy use in IVF, finding limited support for routine adjuvant immunomodulating treatments. View the Committee Opinion
Correct coding for laboratory procedures during assisted reproductive technology cycles (2016)
This document provides updated coding information for services related to assisted reproductive technology procedures. View the Coding Committee Document
Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion (2014)
A general overview for good management practices within the endocrinology, andrology, and embryology laboratories in the United States. View the Recommendation
Best practices of ASRM and ESHRE: a journey through reproductive medicine (2012)
ASRM and ESHRE are the two largest societies in the world whose members comprise the major experts and professionals working in reproductive medicine. View the Committee Joint GuidelineTopic Resources
View more on the topic of gestational carriers and surrogacy
The Current Landscape of International/Foreign Intended Parentage (IP) Exclusion Laws
ASRM urges evidence-based gestational carrier policies that prevent abuse, protect families, and reject nationality-based restrictions on family building. View the Advocacy Resource
ASRM Today: Gestational Carriers and LGBTQ+ Family Building
Explore gestational carriers in LGBTQ+ family building, including emotional, legal, medical, and psychosocial considerations for intended parents. Listen to the Episode
Fertility and Sterility On Air - Live from PCRS 2026 Annual Meeting F&S Fellow Debate
Fertility & Sterility On Air explores elective vs medically indicated gestational carrier use, featuring ASRM experts debating ethics, access, and risk. Listen to the Episode
Fertility and Sterility On Air - Roundtable: Concurrent Surrogacy
Fertility & Sterility Roundtable explores ethics of concurrent gestational surrogacy with experts debating pros and cons of overlapping pregnancies debate. Listen to the Episode
Just the Facts: Gestational Carrier Care in the United States
Gestational carrier (GC) care is a long-established, medically indicated specialized modality of assisted reproductive technology (ART). View the Advocacy Resource
ASRM Center for Policy and Leadership Releases Policy Report on Gestational Carrier Pregnancies
ASRM Center for Policy and Leadership released a report discussing gestational carrier policy in the U.S. discussing it's impact and how lawmakers should proceed going forward. View the Press Release
Gestational Carrier Policy in the United States
Third-party reproduction using a gestational carrier (GC) is a family-buildingoption carried out in accordance with existing legal frameworks. View the Advocacy Resource
Third-party billing for an Embyo Transfer on a Gestational Carrier
The IP’s insurance plan has coverage for embryo transfer. Upon further clarification with the insurance plan, the IP has confirmed View the Answer
Who to bill for gestational carrier services if intended parents have insurance?
I wanted to inquire about guidelines for billing services to a surrogate’s insurance company if intended parents purchased the insurance coverage. View the Answer
Mental health assessment for donors and intended parents
Is it appropriate to use 96156 or 96167 for mental health professional (MHP) counseling of gamete/embryo donors and gestational carriers? View the Answer
Diagnosis code for donation
What is the diagnosis code for an embryo donation versus egg donation? View the Answer
Journal Club Global: Absolute uterine infertility a Cornelian dilemma: uterine transplantation or surrogacy?
Absolute uterine infertility presents as a Cornelian dilemma for patients and providers. View the Video
Gestational Carrier
I would like to confirm ASRM’s opinion on the best code to use for a gestational carrier cycle. View the Answer
Diagnosis Code For Same-Sex Egg Donation
We have a same-sex male couple with insurance coverage for IVF. View the Answer
Consideration of the gestational carrier: an Ethics Committee opinion (2023)
Intended parents engage with gestational carriers (GCs) to achieve their personal reproductive goals. View the Committee Opinion
Recommendations for practices using gestational carriers: a committee opinion (2022)
This document provides the latest recommendations for the screening, evaluation, and legal counseling of gestational carriers and intended parents. View the Committee OpinionTopic Resources
View more on the topic of third-party reproduction
Appropriate ICD-10 Codes for Infectious Disease Screening
We are seeking official ASRM guidance regarding appropriate ICD-10 coding for View the Answer
ASRM Center for Policy and Leadership Releases Policy Report on Gestational Carrier Pregnancies
ASRM Center for Policy and Leadership released a report discussing gestational carrier policy in the U.S. discussing it's impact and how lawmakers should proceed going forward. View the Press Release
Gestational Carrier Policy in the United States
Third-party reproduction using a gestational carrier (GC) is a family-buildingoption carried out in accordance with existing legal frameworks. View the Advocacy Resource
Who to bill for gestational carrier services if intended parents have insurance?
I wanted to inquire about guidelines for billing services to a surrogate’s insurance company if intended parents purchased the insurance coverage. View the Answer
Mental health assessment for donors and intended parents
Is it appropriate to use 96156 or 96167 for mental health professional (MHP) counseling of gamete/embryo donors and gestational carriers? View the Answer
Family members as gamete donors or gestational carriers: an Ethics Committee opinion (2024)
The use of adult intrafamilial gamete donors and gestational surrogates is ethically acceptable when all participants are fully informed and counseled. View the Committee Document
Diagnosis code for donation
What is the diagnosis code for an embryo donation versus egg donation? View the Answer
Submitting female codes under a male patient in a donor cycle
We got a rejection from the clearinghouse for using a female diagnosis under a male patient. View the Answer
Billing donor services to IP’s insurance
When an intended parent has donor coverage under their insurance, how do we bill the donor services to their insurance? View the Answer
Reimbursement for donor egg
My wife and I are going through a fertility treatment process, and we have purchased a donor egg out-of-pocket from a donor bank. View the Answer
Misconduct in third-party assisted reproductive technology by participants and nonmedical professionals or entities: an Ethics Committee opinion (2023)
In some instances, it is permissible for the physician to disclose information to the affected party or to decline to provide or continue to provide care. View the Committee Opinion
Defining embryo donation: an Ethics Committee opinion (2023)
The ethical appropriateness of patients donating embryos to other patients for family building, or for research, is well established.
View the Committee Opinion
Gestational Carrier
I would like to confirm ASRM’s opinion on the best code to use for a gestational carrier cycle. View the Answer
Donor Screening
Is there a specific CPT code used for Donor Physical Exams or would a practice just bill using the appropriate E&M Code? View the Answer
Egg Culture and Fertilization: Same Gender
A same-sex male couple requested half their donor eggs be fertilized with sperm from male #1 and the other half fertilized from male #2. View the Answer
Donor Egg Infectious Disease Lab Screening
The issue we are experiencing is outside labs billing with Z11.3 are getting denials stating improper ICD-10 for the services billed. View the Answer
Donor Egg Lot Acquisition
What is the code for egg lot acquisition? View the Answer
Donor Eggs-Physical Exam
Is there a specific CPT code used for Donor Physical Exams or would a practice just bill using the appropriate E&M Code? View the Answer
Donor Egg-Retrieval On Recipient's Claim
Is the donor egg retrieval included on the bill to insurance with the first IVF treatment for the recipient? View the Answer
Donor Embryos
Could you give guidance for the correct ICD-10 code(s) to use when a patient is doing an Anonymous Donor Embryo Transfer cycle? View the Answer
Claim Form for Donor Egg Retrieval
What bill form is used of IVF donor egg retrieval? View the Answer
